Genesis Drug Discovery & Development (GD³)
Company Management

Genesis Drug Discovery & Development (GD³)

Biotechnology Research Hamilton, New Jersey, United States 9 employees
Employees
9
Contacts
4
Emails
4
Phones
1

Genesis Drug Discovery & Development (GD³) Overview

Headquarters
Hamilton, New Jersey, United States
Website
gd3services.com
Industry
Biotechnology Research
Employees
9
Founded
2017
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Genesis Drug Discovery & Development (GD³)

Genesis Drug Discovery and Development (GD3), a member of Genesis Global Group, is a contract research organization focused on providing services to support preclinical drug development programs from discovery to candidate selection. Our diversified portfolio of services covers all the areas of preclinical drug discovery/development including Discovery Biology, Chemistry, DMPK/in-vivo pharmacology and Toxicology. The portfolio spans a wide range of therapeutic areas include oncology, ocular, inflammation, metabolic diseases, and microbiome.

Genesis Drug Discovery & Development (GD³) Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
1
25.0% coverage

Genesis Drug Discovery & Development (GD³) Org Chart

Sample employees and titles
Name Title Contact
Anthony Rohr Director of Business Development
Email Phone
Madeline Farley, Ph.d. Chief Scientific Officer, Biochemistry
Email
Graham Fletcher Pharmacology and Drug Development Cso
Email
Miglena Prabagar
Email

Employees by Management Level

Individual contributor 3 profiles
Executive 2 profiles
Director 1 profile
Associate / junior 1 profile

Department Contact Coverage

Department Contacts Email Phone
Executive 2 2 1
General 2 2 0

Genesis Drug Discovery & Development (GD³) Tech Stack

Data / AI 1 profile

Compare Similar Companies to Genesis Drug Discovery & Development (GD³)